NCT00115973

A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump

An Open-Label, Stepwise Basal Insulin Dose Titration Study Using Continuous Subcutaneous Insulin Infusion (CSII) in Oral Antidiabetic Drug-Treated Type 2 Diabetes Mellitus Subjects Followed by a 10-Week Out-Patient Maintenance Phase

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 71 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 30 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This trial is conducted in the United States of America (USA). This is an in-patient trial investigating stepwise dose increase in a period of up to 3-weeks followed by a 10-week out-patient maintenance period. A telephone contact visit is scheduled as a follow-up for the final clinic visit. A subject's participation in this trial would be expected to be up to 16 weeks.

Conditions

• Diabetes
• Diabetes Mellitus, Type 2
• Delivery Systems

Interventions

Type	Name	Description
DEVICE	pump
DRUG	insulin aspart

Timeline

• Start date: 2005-06-01
• Primary completion: 2006-01-01
• Completion: 2006-01-01
• First posted: 2005-06-27
• Last updated: 2016-10-18

Locations

6 sites across 1 country: United States